The threat of fungal infections is growing. Why is it so hard to make new drugs?

Last summer, the Food and Drug Administration denied an application for a new antifungal drug called olorofim, sending it back to the company with a request for more data. If approved, it would have been the first time since the early 2000s that the FDA cleared an antifungal that works in an…#fda #arturocasadevall #baltimore #valley #greatplains #aspergillus #normanvanrhijn #unitedkingdom #leahcowen #universityoftoronto
Source: Reuters: Health - Category: Consumer Health News Source Type: news